戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 and TNF-related activation-induced cytokine (TRANCE).
2 F-kappaB ligand; also known as OPGL, ODF, or TRANCE).
3 anner that likely requires local delivery of TRANCE.
4 r (TNF)-related activation-induced cytokine (TRANCE), a member of the TNF family expressed on activat
5 r (TNF)-related activation-induced cytokine (TRANCE), a member of the TNF family, is a dendritic cell
6 KL)/TNF-related activation-induced cytokine (TRANCE), a primarily T-cell restricted TNF family member
7 r (TNF)-related activation-induced cytokine (TRANCE), a TNF family member, before immunization enhanc
8 factor-related, activation-induced cytokine (TRANCE), a tumor necrosis factor family member, mediates
9                                              TRANCE, a TNF family member, and its receptor, TRANCE-R,
10                We recently demonstrated that TRANCE activates Akt via a mechanism involving TRANCE re
11    These results define a mechanism by which TRANCE activates Src family kinases and PKB and provide
12                    Here, we demonstrate that TRANCE activates the antiapoptotic serine/threonine kina
13 a), TNF-related activation-induced cytokine (TRANCE, also referred to as osteoprotegerin ligand), and
14 ppaB, and its ligand RANKL (initially termed TRANCE, also termed ODF and OPGL), are a TNF superfamily
15                                              TRANCE and CD40L-mediated Akt activation is defective in
16 , myeloma cell lines stimulate expression of TRANCE and inhibit expression of OPG by stromal cells.
17                   Thus, we propose that both TRANCE and LTalphabeta regulate the colonization and clu
18  subjects were writing, in both dissociative trance and non-trance states.
19                            Our data identify TRANCE and OPG as key cytokines whose deregulation promo
20 nto question previous assumptions concerning trance and rock art imagery.
21 tes have raged over the relationship between trance and rock art, unambiguous evidence of the consump
22  factor-related activation-induced cytokine (TRANCE) and decrease in its decoy receptor, osteoprotege
23  of TNF-related activation-induced cytokine (TRANCE) and receptor activator of NF-kappaB (RANK) was c
24 or (TNF)-related activation-inducing ligand (TRANCE) and TNF-related apoptosis-induced ligand (TRAIL)
25  factor-related activation-induced cytokine (TRANCE), and its receptors, receptor activator of nuclea
26 Unlike soluble OPG receptors, which preclude TRANCE binding to RANK, OP3-4 shows the ability to modul
27 mplications for the functional regulation of TRANCE by potentially more than one protease.
28 rotein and of a peptide corresponding to the TRANCE cleavage site by TACE occurs at the same site tha
29                A recombinant soluble form of TRANCE composed of the entire ectodomain induced c-Jun N
30                                    Moreover, TRANCE cooperates with CD40 ligand or TNF-alpha to furth
31 em (AREG, AXIN1, CLEC4C, CXCL10, CXCL11, and TRANCE) correlated strongly with bacterial translocation
32 ity (AUC: 0.88), including CLEC7A, EIF4EBP1, TRANCE, CXCL10, HGF, KRT19, LAMP3, CKAP4, CXADR, and ITG
33          We report the skeletal phenotype of TRANCE-deficient mice and its rescue by the TRANCE trans
34 c overexpression of TRANCE in lymphocytes of TRANCE-deficient mice rescued osteoclast development in
35                                              TRANCE-deficient mice showed severe osteopetrosis, with
36  that subjects produced complex content in a trance dissociative state suggests they were not merely
37                                              TRANCE does not induce the proliferation of or increase
38                          We propose that the TRANCE ectodomain is released from cells by TACE or a re
39  cells; and (iv) that in vitro cleavage of a TRANCE ectodomain/CD8 fusion protein and of a peptide co
40                           In sharp contrast, TRANCE expression by stromal cells was completely indepe
41                                 In addition, TRANCE expression is restricted to lymphoid organs and T
42 sis, the functional consequence of increased TRANCE expression, is counteracted by addition of a reco
43  factor-related activation-induced cytokine (TRANCE) expression.
44                                          The TRANCE gene encodes a type II membrane protein of 316 am
45 rane by a metalloprotease; (ii) that soluble TRANCE has potent dendritic cell survival and osteoclast
46                                              TRANCE, however, does not exert any significant effect o
47 is an important component of the function of TRANCE in bone and immune homeostasis.
48 ests a potential role for ADAM19 in shedding TRANCE in cells where both molecules are highly expresse
49                   In addition, expression of TRANCE in ILF was concentrated just beneath the follicle
50                 Transgenic overexpression of TRANCE in lymphocytes of TRANCE-deficient mice rescued o
51 is not required for shedding of TNFalpha and TRANCE in mouse embryonic fibroblasts, its overexpressio
52 vertase (TACE) can cleave immunoprecipitated TRANCE in vitro in a fashion that mimics the cleavage ob
53 constant at all time points, suggesting that TRANCE-induced MITF, not PU.1 expression, is one of the
54 sion by PU.1/MITF is further enhanced by the TRANCE-induced MKK6/p38 signaling cascade.
55 -/-) mice developed normally, but CD40L- and TRANCE-induced survival and IL-12 production was abolish
56                                      In DCs, TRANCE induces the expression of proinflammatory cytokin
57                                     However, TRANCE induction is significantly suppressed when cells
58 is counteracted by addition of a recombinant TRANCE inhibitor, RANK-Fc, to marrow/myeloma cocultures.
59                                              TRANCE inhibits apoptosis of mouse bone marrow-derived D
60                                   Therefore, TRANCE is a new DC-restricted survival factor that media
61                                              TRANCE is an immediate early gene up-regulated by TCR st
62                                              TRANCE is most highly expressed in thymus and lymph node
63 CE occurs at the same site that is used when TRANCE is shed from cells into the supernatant.
64     TNF-related activation-induced cytokine (TRANCE) is a member of the TNF family recently identifie
65 r (TNF)-related activation-induced cytokine (TRANCE) is a TNF family member essential for osteoclast
66 such as dancing) or through reverie (such as trance), it is usually the temporal qualities of the mus
67       In this report we demonstrate (i) that TRANCE, like TNF-alpha, is made as a membrane-anchored p
68 , and OSCAR in TRANCE-treated (RAW 264.7) or TRANCE/M-CSF-treated cells (primary osteoclasts) reveal
69 ition of Src family kinase inhibitors blocks TRANCE-mediated PKB activation in osteoclasts.
70                                        Thus, TRANCE-mediated regulation of the skeleton is complex, a
71                                   Transgenic TRANCE-mediated restoration of LN development requires L
72 nstrate that the defective LN development in TRANCE(-/)- mice correlates with a significant reduction
73          Transgenic TRANCE overexpression in TRANCE(-/)- mice results in selective restoration of thi
74 fate of CD45(+)CD4(+)CD3(-) cells similar to TRANCE(-/)- mice.
75                    Upon TCR/CD3 stimulation, TRANCE mRNA and surface protein expression are rapidly u
76                          We report here that TRANCE mRNA is constitutively expressed in memory, but n
77      The TNF-family molecule RANK-L (RANK-L, TRANCE, ODF) and its receptor RANK are key regulators of
78                  These findings suggest that TRANCE on stromal cells contributes to the differentiati
79 s indicate that in vivo, deregulation of the TRANCE-OPG cytokine axis occurs in myeloma, but not in t
80 erstand complex biological functions of RANK-TRANCE-OPG receptors and also can be used as a platform
81 g of the tumor necrosis factor family member TRANCE/OPGL in different cell types.
82 ces osteoclast survival in response to RANKL/TRANCE/OPGL, providing evidence that Src family kinases
83                                   Transgenic TRANCE overexpression in TRANCE(-/)- mice results in sel
84 ex with TRAF6-binding peptides from CD40 and TRANCE-R (also known as RANK), members of the TNFR super
85                           Here, we show that TRANCE-R and CD40 recruit TRAF6, Cbl family-scaffolding
86 ed competition between TRAF proteins for the TRANCE-R and the possibility of a TRAF-independent NF-ka
87                                 Signaling by TRANCE-R appears to be dependent on TNF receptor-associa
88            Here, we show that high levels of TRANCE-R are detected on mature dendritic cells (DCs) bu
89 motif, which is present not only in CD40 and TRANCE-R but also in the three IRAK adapter kinases for
90 utants revealed that multiple regions of the TRANCE-R can mediate NF-kappaB activation.
91   Furthermore, transfection experiments with TRANCE-R deletion mutants revealed that multiple regions
92                                  Analysis of TRANCE-R deletion mutants suggested that the TRAF2 and T
93        The recruitment of Cbl-b and c-Cbl to TRANCE-R is dependent upon the activity of Src-family ki
94  and TRAF6 interact with each other and with TRANCE-R upon receptor engagement.
95 interactions between the cytoplasmic tail of TRANCE-R with TRAF1, TRAF2, TRAF3, TRAF5, and TRAF6.
96                         The TRANCE receptor (TRANCE-R), recently identified as receptor activator of
97 fter interaction with its putative receptor (TRANCE-R).
98 t via a mechanism involving TRANCE receptor (TRANCE-R)/RANK, TRAF6, and c-Src.
99 ANCE, a TNF family member, and its receptor, TRANCE-R, are critical regulators of dendritic cell and
100 ting protein (TRIP), substantially inhibited TRANCE-R-mediated NF-kappaB activation, suggesting a rol
101 ignal transducers as important components of TRANCE-R-mediated NF-kappaB activation.
102 tor receptor (TNFR) family members (GITR and TRANCE-R/RANK) in Treg biology, the improved understandi
103 ed osteoclast activation that occurs through TRANCE-RANK causes osteopenic disorders such as osteopor
104 lts demonstrate that CD40L(-/-) mice use the TRANCE-RANK costimulatory pathway to promote IL-12 produ
105 ng mice lacking osteoprotegerin or by adding TRANCE (RANKL, Tnfsf11).
106 n osteoclast differentiation and activation, TRANCE/RANKL also functions to augment T-cell dendritic
107 onstrated that the degree of bone erosion in TRANCE/RANKL knockout mice was dramatically reduced comp
108 cal scoring, was comparable in wild-type and TRANCE/RANKL knockout mice.
109 n was present in both control littermate and TRANCE/RANKL knockout mice.
110 , we generated inflammatory arthritis in the TRANCE/RANKL knockout mouse using a serum transfer model
111 r activator of nuclear factor-kappaB ligand (TRANCE/RANKL) is an essential factor for osteoclast diff
112                                          The TRANCE receptor (TRANCE-R), recently identified as recep
113 ANCE activates Akt via a mechanism involving TRANCE receptor (TRANCE-R)/RANK, TRAF6, and c-Src.
114  alters the biological functions of the RANK-TRANCE receptor complex by facilitating a defective rece
115                               High levels of TRANCE receptor expression are found on mature dendritic
116  Here, we show that in vivo treatment with a TRANCE receptor fusion protein results in a decrease in
117 ow that activated T and B cells also express TRANCE receptor, but only at low levels.
118 s some properties with RANK, the first RANKL/TRANCE receptor, we discuss how the balance between RANK
119  of TNF-related activation-induced cytokine (TRANCE)-receptor activator of NF-kappaB (RANK) interacti
120                                   One of the TRANCE sheddases is induced by the tyrosine phosphatase
121                                 At least two TRANCE shedding activities emerged, both of which are di
122 in COS-7 cells results in strongly increased TRANCE shedding.
123 NK, OP3-4 shows the ability to modulate RANK-TRANCE signaling pathways and alters the biological func
124 ally documented to have used Datura to enter trance states, little evidence exists to associate it wi
125 writing, in both dissociative trance and non-trance states.
126 ber TNF-related activation-induced cytokine (TRANCE) that are produced by osteoblasts/stromal cells i
127 tor activator of NF-kappaB ligand (RANKL, or TRANCE, TNFSF11) to carry out bone resorption.
128 egulatory T cells (Treg), whereas 4-1BBL and TRANCE together can stimulate T cells and dendritic cell
129  TRANCE-deficient mice and its rescue by the TRANCE transgene specifically expressed in lymphocytes.
130 plate defects were largely unimproved by the TRANCE transgene.
131 ression patterns of MITF, PU.1, and OSCAR in TRANCE-treated (RAW 264.7) or TRANCE/M-CSF-treated cells
132                                              TRANCE (tumor necrosis factor [TNF]-related activation-i
133                                              TRANCE upregulates Bcl-xL expression, suggesting a poten
134 stensibly transforming during initiation and trance, violating folk-intuitions of humanness to assure
135 E was mapped to chromosome 13q14 while mouse TRANCE was located to the portion of mouse chromosome 14
136                                        Human TRANCE was mapped to chromosome 13q14 while mouse TRANCE
137 sis factor (TNF) cytokine family, designated TRANCE, was cloned during a search for apoptosis-regulat
138 g psychography compared to their normal (non-trance) writing.

 
Page Top